JUL 11, 2018 2:13 AM PDT

'Acetazolamide' Used To Treat Altitude Sickness, Slows Down the Development of Glioblastoma

WRITTEN BY: Nouran Amin

 

 

Acetazolamide, which is sold under the trade name Diamox and used to treat altitude sickness, is considered inexpensive to manufacture and easy to administer.

"I take it myself, whenever I go to the Rocky Mountains," explains study director Bahktiar Yamini, MD, a professor of neurosurgery at the University of Chicago Medicine. Although acetazolamide has minimal side effects, users report "a metallic taste when drinking something carbonated."

Acetazolamide is a studied to be a carbonic anhydrase inhibitor drug that can restore another drug's ability to eradicate tumor cells.

More specifically, acetazolamide when added to a drug called temozolomide (TMZ), it was seen to slow down the progression of glioblastoma in mouse models.

Acetazolamide enables TMZ to damage the DNA present in tumor cells in order to inhibit its growth.

Researchers discovered that glioblastoma patients with increased levels of a protein called BCL-3 (B cell CLL/lymphoma 3) were unresponsive to the effects exerted by the chemotherapeutic drug, TMZ. In particular, BCL-3 protects cancer cells from TMZ damage by activating a protective enzyme known as carbonic anhydrase II.

"We tested this combination treatment strategy in several animal models," Yamini said. “It cured some of them. Others had a 30 to 40 percent increase in survival time.”

Furthermore, the researchers examined BCL-3 levels from earlier human studies and found that patients with lower levels of BCL-3 who were treated with TMZ had a higher survival rate than patients who had high levels of this biomarker.

"An important feature of predictors like BCL-3 is that they are informative," the authors note. "They can identify pathways to improve treatment response."

By studying those pathways, carbonic anhydrase inhibitors were identified, such as acetazolamide, as a way to decrease the resistance to temozolomide.

"Our data," they note, demonstrate that it is the "induction of CAII by TMZ that is important in modulating response to therapy."

Confirming the use of BCL-3 to predict which patients will benefit from the use of temozolomide will require validation through clinical trials.

Additionally, the authors believe that repurposing the use of acetazolamide along with temozolamide might be particularly effective for patients with tumors that have high BCL-3 expression.

About the Author
  • Nouran is a scientist, educator, and life-long learner with a passion for making science more communicable. When not busy in the lab isolating blood macrophages, she enjoys writing on various STEM topics.
You May Also Like
APR 21, 2021
Drug Discovery & Development
Dietary Supplement Successfully Treats Mice with Schizophrenia
APR 21, 2021
Dietary Supplement Successfully Treats Mice with Schizophrenia
Researchers from the University of Tokyo have found that betaine, a dietary supplement found in sugar beets, reduces beh ...
MAY 17, 2021
Cell & Molecular Biology
Survey Results: Where Is Pluripotent Stem Cell Research Now?
MAY 17, 2021
Survey Results: Where Is Pluripotent Stem Cell Research Now?
Human pluripotent stem cell (hPSC) lines are now commonly used across the globe. In the lab, researchers rely on hPSCs t ...
JUN 01, 2021
Immunology
Nanoparticles Designed to Enhance Seasonal Flu Vaccines
JUN 01, 2021
Nanoparticles Designed to Enhance Seasonal Flu Vaccines
Seasonal flu vaccines only work around 40 to 60 percent of the time, says the U.S. Centers for Disease Control and Preve ...
JUN 28, 2021
Drug Discovery & Development
Ultra-Thin Spinal Implants Could Treat Severe Pain
JUN 28, 2021
Ultra-Thin Spinal Implants Could Treat Severe Pain
Researchers from the University of Cambridge have built a minimally invasive, ultra-thin, inflatable spinal cord stimula ...
JUL 22, 2021
Health & Medicine
High Stress and Self Medication: Variables of Teenage Cannabis Use and Mental Health
JUL 22, 2021
High Stress and Self Medication: Variables of Teenage Cannabis Use and Mental Health
It is theorized that young members of the LGB community are thought to be heavier cannabis users. This heavier, and pote ...
JUL 23, 2021
Cancer
New Drug Eradicates Breast Cancer Tumors in Days
JUL 23, 2021
New Drug Eradicates Breast Cancer Tumors in Days
A new drug can kill between 95 and 100% of cancer cells in mice with human estrogen-receptor-positive breast cancer. The ...
Loading Comments...